Tongue carcinoma infrequently harbor common actionable genetic alterations - Wikidata - thesis-toulmin - TriplyDB

Tongue carcinoma infrequently harbor common actionable genetic alterations

Tongue carcinoma infrequently harbor common actionable genetic alterations

http://www.wikidata.org/entity/Q34256064

about

Mutational landscapes of tongue carcinoma reveal recurrent mutations in genes of therapeutic and prognostic relevance.Oncogenes and tumor suppressor genes in squamous cell carcinoma of the tongue in young patients.Genetic determinants in head and neck squamous cell carcinoma and their influence on global personalized medicine.Association of Nrf2 with airway pathogenesis: lessons learned from genetic mouse models.Nrf2 regulates cellular behaviors and Notch signaling in oral squamous cell carcinoma cells.Genomic sequencing and precision medicine in head and neck cancers.Targeting non-canonical autophagy overcomes erlotinib resistance in tongue cancer.Survival of patients with head and neck squamous cell carcinoma by housing subsidy in a tiered public housing system.Prevalence of EGFR Tyrosine Kinase Domain Mutations in Head and Neck Squamous Cell Carcinoma: Cohort Study and Systematic Review.Long noncoding RNA EGFR-AS1 mediates epidermal growth factor receptor addiction and modulates treatment response in squamous cell carcinoma.Lip cancer and pre-cancerous lesions harbor TP53 mutations, exhibit allelic loss at 9p, 9q, and 17p, but no BRAFV600E mutations.Suppression of c-MET overcomes erlotinib resistance in tongue cancer cells

P2860

Q30665308-87C1B43C-B656-45A3-A822-214451B76FC5 Q35550271-122B092A-5358-4053-B67B-EFAC972E52E5 Q37164556-88F1B1DF-A065-49FC-B2B2-C043C49796D8 Q38551047-E765171D-8857-447D-9885-C6FC6850F370 Q38618135-3E727620-7B44-4F37-A6D9-57E81C956713 Q38776454-491EA4ED-5294-4820-9874-30AD69E21BB2 Q38800568-FA7FA7BF-676F-482F-B3D4-0DAD8E13E079 Q38991911-588618C0-03E8-48A8-94CB-226E02553FB7 Q39073840-25093557-8277-4D3B-A4C2-99D460876AAB Q47787176-7EBE6552-EC50-4946-A79F-4E96F75D81EE Q53464584-822A73EC-D5CB-4D7D-AC3C-1354293F8E74 Q58762813-A62252A0-BF83-4BD9-86DB-A9B07E9D76FD

P2860

Tongue carcinoma infrequently harbor common actionable genetic alterations

http://www.wikidata.org/entity/Q34256064

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Tongue carcinoma infrequently harbor common actionable genetic alterations

@ast

Tongue carcinoma infrequently harbor common actionable genetic alterations

@en

Tongue carcinoma infrequently harbor common actionable genetic alterations

@nl

type

label

Tongue carcinoma infrequently harbor common actionable genetic alterations

@ast

Tongue carcinoma infrequently harbor common actionable genetic alterations

@en

Tongue carcinoma infrequently harbor common actionable genetic alterations

@nl

prefLabel

Tongue carcinoma infrequently harbor common actionable genetic alterations

@ast

Tongue carcinoma infrequently harbor common actionable genetic alterations

@en

Tongue carcinoma infrequently harbor common actionable genetic alterations

@nl

P1433

Q34256064-5C10ED3B-4F06-4BE5-B0BD-1621C4176DC7

P1476

Q34256064-1A676C41-6E67-4932-AEFD-DF35DD0E9DD1

P2093

Q34256064-3B3F2927-5209-49D2-BD32-4E9276C5114B

Q34256064-47AA522C-6EB9-4170-BE10-06E2A30527FA

Q34256064-78FD0DB9-A44D-483E-80FE-75B951B8F489

Q34256064-A1CDE763-27DA-4A88-8603-879E34C5C7FE

Q34256064-A4FB0A3C-E88F-42B2-B2C4-F70AB6C27843

Q34256064-BC39D949-9B6E-4FC5-A9D4-45E1148E809A

Q34256064-E0D0C3C9-320A-4AA6-A0E4-B32F174DE7D8

Q34256064-E8CC1AB4-7600-4D92-8D1C-2BDBF195E209

P2860

Q34256064-00D8C791-5D68-4A96-A05A-5AC6D9999BCF

Q34256064-034E8548-5408-42EC-BD06-49FB775E8333

Q34256064-0ACF7465-9643-4BD6-94CC-0378308FC944

Q34256064-0B40A175-EFC9-424A-BB10-A71E53EFA76B

Q34256064-0C5F04C8-1D09-48F1-BFCB-E3CE10CEE439

Q34256064-0E2925C1-B5CB-48DC-BE56-05EC2AEAA262

Q34256064-128A7EFB-F5FC-4000-9751-A5F87BB24FFC

Q34256064-16A56C27-B15A-4224-A6AD-82381EA64365

Q34256064-1CD3C571-3A97-4B3B-876E-7F7C0F0C29D1

Q34256064-2AA7D97E-EFD0-4BE3-9B0F-E88935F8C610

P2888

Q34256064-8F1FC42A-89D6-4091-8967-A29C6EB07A6B

P304

Q34256064-002FD4EA-3035-4AC3-93D6-4C7341C4D0D1

P31

Q34256064-354285B2-ACF7-4B72-89D8-3A9C36A2668C

P356

Q34256064-849482C4-8895-4918-A913-B8C0AD280354

P407

Q34256064-80E8C6EA-A5CE-4569-B6C2-D7A3077A3F23

P478

Q34256064-2D219FC1-6B8F-4837-BDDF-5F1EEBF305ED

P50

Q34256064-B7AE9B36-35DB-4FA2-88B5-7467C3CAD479

P577

Q34256064-645340AF-7A0A-47E1-A657-F8E0101A896E

P5875

Q34256064-EF84B456-15AA-4B15-B3F5-1372279A534F

P6179

Q34256064-810F3042-5D93-4049-88EB-682015F87FCD

P698

Q34256064-051E5A21-4138-4F65-9830-8E4A56527191

P932

Q34256064-1176DFCE-B04A-4089-A7F0-ADF5DA5707D9

P356

1471-2407-14-679

P1433

P1476

Tongue carcinoma infrequently harbor common actionable genetic alterations

@en

P2093

Daniel S W Tan

http://www.w3.org/2001/XMLSchema#string

Dawn P Lau

http://www.w3.org/2001/XMLSchema#string

Fui Teen Chong

http://www.w3.org/2001/XMLSchema#string

Hui Sun Leong

http://www.w3.org/2001/XMLSchema#string

N Gopalakrishna Iyer

http://www.w3.org/2001/XMLSchema#string

Pui Hoon Sew

http://www.w3.org/2001/XMLSchema#string

Tony K H Lim

http://www.w3.org/2001/XMLSchema#string

Weining Wang

http://www.w3.org/2001/XMLSchema#string

P2860

The Catalogue of Somatic Mutations in Cancer (COSMIC)

The metabolic basis of kidney cancer

Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.

Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial.

Major clinical response to a BRAF inhibitor in a patient with a BRAF L597R-mutated melanoma.

Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1

The mutational landscape of head and neck squamous cell carcinoma

The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma.

A rapid, sensitive, reproducible and cost-effective method for mutation profiling of colon cancer and metastatic lymph nodes.

Targeting cancer stem cell plasticity through modulation of epidermal growth factor and insulin-like growth factor receptor signaling in head and neck squamous cell cancer.

P2888

1471-2407-14-679

P304

679

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-14-679

http://www.w3.org/2001/XMLSchema#string

P407

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Sai Sakktee Krisna

P577

2014-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265861948

http://www.w3.org/2001/XMLSchema#string

P6179

1002730589

http://www.w3.org/2001/XMLSchema#string

P698

25234657

http://www.w3.org/2001/XMLSchema#string

P932

4177593

http://www.w3.org/2001/XMLSchema#string